SignalMed+ Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
SignalMed+ General Information
Description
Developer of EEG monitoring and analysis software intended to support monitoring and prediction of brain states during anesthesia. The company's technology employs real-time electroencephalogram signal processing combined with computational neuroscience modeling and artificial intelligence to extract hidden patterns from high-dimensional brain data, enabling hospitals to optimize anesthesia control and provide early detection of recovery in comatose patients.
Contact Information
Website
www.signalmedplus.comCorporate Office
- 229 rue Saint-Honore
- 75001 Paris
- France
Corporate Office
- 229 rue Saint-Honore
- 75001 Paris
- France
SignalMed+ Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue |
SignalMed+ Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Paris Biotech Sante | Accelerator/Incubator |
SignalMed+ FAQs
-
When was SignalMed+ founded?
SignalMed+ was founded in 2021.
-
Where is SignalMed+ headquartered?
SignalMed+ is headquartered in Paris, France.
-
What industry is SignalMed+ in?
SignalMed+’s primary industry is Decision/Risk Analysis.
-
Is SignalMed+ a private or public company?
SignalMed+ is a Private company.
-
What is SignalMed+’s current revenue?
The current revenue for SignalMed+ is .
-
Who are SignalMed+’s investors?
Paris Biotech Sante has invested in SignalMed+.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process